NFCR Writer David Perry, Author at NFCR - Page 8 of 9

NFCR Writer David Perry

Flu Virus Harnessed to Fight Pancreatic Cancer

Led by Dr. Gunnel Halldén of Queen Mary University in London, a team of scientists modified a common flu virus to successfully inhibit the growth of pancreatic cancer. The new technique could potentially become a promising new treatment for patients with the aggressive disease, and could be combined with existing…...

Read more

Researchers Develop Antibody to Fight Colorectal Cancer

President Bill Clinton declared March Colorectal Cancer Awareness Month in 2000, highlighting a disease that represents eight percent of all new cancers diagnosed yearly and, out of the estimated 135,430 people who developed it just last year, caused an estimated 50,260 deaths in the United States alone. As outlined in…...

Read more

Study Better Predicts Stomach Cancer

Although stomach (AKA gastric) cancer is the third deadliest cancer in the world, claiming an estimated 10,960 lives in the United States alone in 2017, it remains one of the more difficult cancers to notice and detect. Indeed, more than two-thirds of patients are diagnosed only after the disease is…...

Read more

“Background Genetic Risk” Studied in Breast Cancer

From a genetic standpoint, the human body is something like a symphony, with individual genes often acting as part of a larger sum. In the case of breast cancer, it can be that no one gene is so mutated as to cause the disease. Rather, cancer results more from the…...

Read more

Protein Fueling Gallbladder Cancer Identified

With February being Gallbladder and Bile Duct Cancer Awareness Month, the National Foundation for Cancer Research wishes to profile a recent study focused on the indication. Like cancers of other organs buried deep within the body, gallbladder cancer is notoriously difficult to diagnosis in its beginning stages; most patients do…...

Read more

Cervical Cancer to “Skyrocket” Among Older Women

A study out of the United Kingdom predicts that while cervical cancer in young women is set to decline 75 percent by 2040, with deaths close to eradicated, women aged 50-64 will see a 62% rise in the disease, leading to a 143% rise in mortality, from 183 deaths in…...

Read more

New Therapeutic Option for Triple-Negative Breast Cancer

Triple-negative breast cancer, one of the deadliest and most aggressive forms of breast cancer, spreads quickly, is resistant to many chemotherapies and is likely to reoccur even after a seemingly successful round of therapies. The cause for the later is the resiliency of a subset of cancer cells called cancer…...

Read more

Genetic Breakthrough in Aggressive Prostate Cancer Research

Cancer researchers at the Thomas Jefferson University in Philadelphia have zeroed in on a specific type of gene loss that sets off large-scale genetic changes that could make prostate cancer both resistant to treatment and more likely to spread. The discovery concerns the retinoblastoma (RB) susceptibility gene, the first “gatekeeper…...

Read more

Hypertension Medicine Linked to Skin Cancer

A research study conducted in both Denmark and the United States found a strong link between skin and lip cancer rates and the use of hydrochlorothiazide, one of the most popular blood pressure medicines in the world. The team, composed of members of the University of Southern Denmark, the Danish…...

Read more

Hormone Receptor Identified for Aggressive Breast Cancer

Triple-negative breast cancer (TNBC), which comprises 15% of diagnosed breast cancers, is an aggressive oncology type defined by the absence of specific receptor proteins that bind the estrogen and progesterone hormones present on normal breast cells. While advances have been made in TNBC therapies, because this particular type of cancer…...

Read more